Geron Corp. (GERN)

1.35 +0.04 (+3.05%) USD  |  NASDAQ  |  Jan 14, 16:00
1.35 0.00 (0.00%) After-Hours: 20:00
More

Geron Total Expenses (% of Annual Revenues)

Total Expenses (% of Annual Revenues) Chart

View Total Expenses (% of Annual Revenues) for GERN.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Expenses (% of Annual Revenues) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Total Expenses (% of Annual Revenues) Range, Past 5 Years

View Total Expenses (% of Annual Revenues) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Expenses (% of Annual Revenues) Benchmarks

View Total Expenses (% of Annual Revenues) Benchmarks
Start Trial
Cassava Sciences, Inc. --
SELLAS Life Sciences Group, Inc. --
Rezolute, Inc. --
GT Biopharma, Inc. --
Ultragenyx Pharmaceutical, Inc. Upgrade